Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, 87,840 bottles from batch No. TZ1236, expiration date, 11/30/2025. The label for recalled Ketorolac Tromethamine Ophthalmic Solution.

Now that summer is here and the school holidays are nearly upon us, many of us are planning time outdoors and travelling in ...

President Joel S. Schuman, MD, highlights the group’s mission and vision for the future—uniting 17 working groups and over 80 stakeholders.

VEGA-3 Phase 3 Study VEGA-3 is the second Phase 3 clinical trial evaluating the safety and efficacy of Phentolamine Ophthalmic Solution 0.75% in subjects with presbyopia.

Opus Genetics Announces VEGA-3 Phase 3 Trial Met its Primary Endpoint for Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia ...

Opus Genetics reports positive Phase 3 trial results for Phentolamine Ophthalmic Solution 0.75% in treating presbyopia.

Prednisolone acetate ophthalmic suspension 1% is a sterile, topical anti-inflammatory agent for ophthalmic use and is indicated for treating steroid-responsive ocular inflammation.

Femtosecond laser-assisted cataract surgery demonstrated improved workflow when performed with a sterile technique vs. a ...

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is one of the 13 Best Healthcare Stocks to Buy Under $10. On June 12, Amneal ...

Stuart Therapeutics, Inc., a clinical-stage drug platform company developing novel therapies for ophthalmic diseases, today announced the initial results of its Phase III clinical trial evaluating ...